Washington Post: Research Supports Medicinal Marijuana

The Washington Post reported in “Research Supports Medicinal Marijuana” on Dr. Donald Abrams’ double-blind study of smoked marijuana for HIV-related peripheral neuropathy that was published in the respected journal Neurology. The findings showed that marijuana can be a safe and effective medication for many people with this condition, and is evidence of marijuana’s therapeutic potential. Yet, no researchers are continuing Dr. Abrams’ promising research, because NIDA’s monopoly and arbitrary review process deters any private sponsor from investing in a medical marijuana drug development effort. The article finished by mentioning MAPS’ victory in our lawsuit against DEA/NIDA, although it unfortunately doesn’t explicitly connect the two issues.